Stay updated on Helix BioPharma Press Releases

Sign up to get notified when there's something new on the Helix BioPharma Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Helix BioPharma Press Releases page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page has added a significant announcement regarding the appointment of a new CFO at Helix BioPharma Corp., while removing a previous announcement about the approval for an extension of a meeting related to asset acquisitions and financing.
    Difference
    16%
    Check dated 2025-06-05T07:48:28.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Helix BioPharma has secured pre-IND candidates LEUMUNA™ and GEMCEDA™ through a strategic acquisition, while the previous announcement regarding the extension of their annual general and special meeting has been removed.
    Difference
    14%
    Check dated 2025-05-22T01:43:36.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page has updated its content regarding Helix BioPharma Corp., replacing the announcement of a private placement with a new capital raising agreement with Kerentech Consulting Ltd.
    Difference
    11%
    Check dated 2025-05-14T19:59:41.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Helix BioPharma Corp. has appointed a new COO and Communications Director, replacing the previous Chief Financial Officer.
    Difference
    14%
    Check dated 2025-04-30T13:39:32.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Helix BioPharma Corp. has appointed Dr. Thomas Mehrling as the new Chief Executive Officer, indicating a strategic shift in leadership to enhance their clinical development efforts.
    Difference
    14%
    Check dated 2025-04-15T23:58:12.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Helix BioPharma Corp. has announced the engagement of an independent trading group for market-making services, while a previous announcement regarding an asset purchase agreement for an oral immune checkpoint inhibitor has been removed.
    Difference
    13%
    Check dated 2025-04-08T19:32:22.000Z thumbnail image

Stay in the know with updates to Helix BioPharma Press Releases

Enter your email address, and we'll notify you when there's something new on the Helix BioPharma Press Releases page.